v3.26.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Market Offering
Common Stock
Common Stock
Market Offering
Additional Paid-in Capital
Additional Paid-in Capital
Market Offering
Accumulated Deficit
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2023     39,107,048        
Stockholders' equity, beginning balance at Dec. 31, 2023 $ 111,374   $ 4   $ 455,443   $ (344,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from at the market offering, net of issuance costs (in shares)     430,349 5,272,538      
Issuance of common stock from at the market offering, net of issuance costs 142 $ 23,528   $ 1 142 $ 23,527  
Stock-based compensation expense 8,826       8,826    
Stock option exercises (in shares)     17,224        
Stock option exercises 35       35    
Net loss $ (70,515)           (70,515)
Stockholders' equity, ending balance (in shares) at Dec. 31, 2024 44,827,159   44,827,159        
Stockholders' equity, ending balance at Dec. 31, 2024 $ 73,390   $ 5   487,973   (414,588)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from at the market offering, net of issuance costs (in shares)     142,957 3,626,701      
Issuance of common stock from at the market offering, net of issuance costs 89 $ 5,903     89 $ 5,903  
Stock-based compensation expense $ 6,245       6,245    
Stock option exercises (in shares) 0            
Net loss $ (60,822)           (60,822)
Stockholders' equity, ending balance (in shares) at Dec. 31, 2025 48,596,817   48,596,817        
Stockholders' equity, ending balance at Dec. 31, 2025 $ 24,805   $ 5   $ 500,210   $ (475,410)